Even though there is no definite cure for rheumatoid arthritis (abbreviated as RA) thus far, there are a number of available medications being offered that are meant to manage its symptoms and in due course improve the condition.
In general, RA drugs may be classified into distinct classes, as enumerated in the succeeding paragraphs. Physicians will probably create proper treatment plan to reduce inflammation and pain of the joints, plus stop cell damage in the joints. Depending on each case, effective treatment can be attained through a combination of the following options:
NSAIDs or Nonsteroidal Anti-inflammatory Drugs
Nonsteroidal Anti-inflammatory Drugs, more commonly known as NSAIDs, are effective in pain relief and inflammation reduction, but don’t serve to protect the joints from further damage. These medications block the body from producing a substance called prostaglandins, which triggers inflammation & pain.
Common NSAID examples are naproxen (Naprosyn, Aleve) and ibuprofen (Motrin, Advil). Some more NSAIDs include etodolac (Lodine), meloxicam (Mobic), ketoprofen (Orudis), Celecoxib (Celebrex), indomethacin, oxaprozin (Daypro), diclofenac (Voltaren, Cataflam), piroxicam (Feldene), and nabumetone (Relafen).
These drugs are regularly prescribed as soon as a final rheumatoid arthritis diagnosis is made. However, But when consumed in excessive dosages for a long time, these drugs can cause severe side effects, such as stomach bleeding, gastric ulcers, and even kidney and liver damage.
Corticosteroids
A different type of medication used for rheumatoid arthritis treatment is corticosteroids. Such medications impact the immune system, thus alleviating inflammation.
Cortisone (Cortone), betamethasone (Celestone Soluspan), methylprednisolone (SoluMedrol, DepoMedrol), prednisolone (Delta-Cortef), triamcinolone (Aristocort), dexamethasone (Decadron), as well as prednisone (Orasone, Deltasone), are some of the most common corticosteroids.
While corticosteroids may be successful in treating rheumatoid arthritis, they have been reported to trigger negative side effects when used in prolonged periods. Some side effects include easy bruising, cataracts, glaucoma, excessive weight gain, diabetes, and thinning bones.
Given their potential to develop adverse side effects, such medications are generally only used as a temporary remedy to curtail sudden attacks of rheumatoid arthritis. On the positive side, just 1 corticosteroid injection can block inflammation of the joint lasting for a long period of time.
Disease Modifying Anti-Rheumatic Drugs or DMARDs
DMARDs (or Disease Modifying Anti-Rheumatic Drugs) pertain to a class of drugs that serve to block the immune system from assaulting the joints, eventually delaying the progression of further joint damage. In treating RA, disease modifying anti-rheumatic drugs are often consumed together with other meds for increased efficiency.
Rheumatoid arthritis commonly causes permanent joint damage, which starts to manifest at the onset. It is because of this that the majority of physicians would prescribe DMARDs soon after making a diagnosis. Individuals are most receptive to DMARDs during the early stages of RA. The sooner DMARDs are used, the more effective it is for the RA patient.
Some DMARD examples include methotrexate (Rheumatrex), cyclosporine (Sandimmune, Neoral), hydroxychloroquine (Plaquenil), gold salts (Ridaura, Solganal, Myochrysine, Ridaura), cyclophosphamide, azathioprine (Imuran), penicillamine (Cuprimine), sulfasalazine (Azulfidine), leflunomide (Arava), and minocycline.
Although various DMARDs have been proven effective in treating RA, the potential for severe side effects is enormous. Long-term DMARD use can lead to toxicity of the bone marrow and liver, susceptibility to infections, allergies (particularly of the skin), and even autoimmunity.
Among the DMARDs listed above, hydroxychloroquine has the lowest potential for producing liver and bone marrow toxicity, and is thus considered as one of the safest DMARDs. The bad news is that hydroxychloroquine is not a powerful drug by itself, and is not effective enough on its own to treat rheumatoid arthritis symptoms.
Conversely, methotrexate is deemed as one of the most powerful DMARDs to use in treating RA because of a number of reasons. Methotrexate has been reported to work in RA treatment without affecting the toxicity of the liver and bone marrow as in the majority of DMARDs. In addition, it works safely and effectively when used together with biological agents, another type of RA drugs to be discussed later. Consequently, methotrexate drugs are frequently prescribed in combination with biological agents in cases where the drug does not control RA on its own. On the other hand, keep in mind that although methotrexate is not as potentially dangerous as others, it still may likely suppress the bone marrow or trigger hepatitis. If this happens, getting regular blood tests are always advised to check the patient’s condition, and to cease treatment at the first indication of problems.
Biological Agents
Biological drugs, also known as biological agents, function to lessen inflammation through various methods.
One example of how biological agents work is by inhibiting tumor necrosis factors (TNFs). Infliximab (Remicade), adalimumab (Humira), and etanercept (Enbrel) are some examples of TNF blockers.
One other method of how biological agents control inflammation is by eradicating B cells. The Rituxan (Rituximab) drug, for instance, fuses itself to B cells, thus killing them.
Other medications that reduce inflammation through their own way are:
- tocilizumab (RoActemra, Actemra), serves to inhibit IL-6 (interleukin)
- anakinra (Kineret), which serves to block IL-1 (interleukin 1)
- abatacept (Orencia), works by inhibiting T-cells
Keep in mind that each biological agent has its own risks for side effects. The potential for side effects must be considered when recommending it to a patient.
Salicylates
Salicylates serve to reduce the body’s production of prostaglandins. Prostaglandins generate arthritis pain and inflammation. In recent years, the use of salicylates have been widely replaced with nonsteroidal anti-inflammatory drugs, primarily due to the fact that salicylates cause severe side effects, such as potential damage to the kidney.
Pain Relief Medications
Finally, various pain relief medications may likewise be used to treat rheumatoid arthritis. Examples of pain relief medications include tramadol (Ultram) and acetaminophen (Tylenol).
While anti-pain drugs neither alleviate inflammation nor delay further joint damage, these medications allow the individual to feel more comfortable and in due course function better. For this reason, anti-pain drugs are absolutely worth considering.
Surgery as a Last Resort
If all these medications prove ineffective, a physician may possibly recommend surgical treatment. Some surgeries meant to treat rheumatoid arthritis are tendon repair, synovectomy (i.e. joint lining removal), as well as arthroplasty (i.e. joint replacement surgery), in which the damaged joint areas are replaced with prosthetics.
Cure For Rheumatoid Arthritis
Rheumatoid arthritis presents with either the acute onset or slow onset of pain and stiffness with functional impairment; if not treated aggressively, it can result in irreversible joint damage. Irreversible joint damage may occur within three to six months of disease onset. If your physician is not making you aware of these grim statistics, then question him or her!
Although RA can occur at any age, most cases are seen in adults between ages 30 and 60 years. Another smaller peak occurs in the 70-80 year age group. Currently, the prevalence of RA is estimated at 15% of the US population; 3 million adults in the United States have been diagnosed with RA. If not adequately treated, progressive deformity will lead to need for joint replacement surgery.
In the United States in 1997 alone, there were 256,000 knee replacements and 117,000 hip replacements associated with arthritis.
Until the entire biology of RA is better understood, treatment strategies must focus on early diagnosis and disease management. Early diagnosis and treatment with disease-modifying anti-rheumatic drugs (DMARDs) are necessary to reduce early joint damage, functional loss, and mortality.
RA is a heterogeneous disease meaning it consists of a wide spectrum of presentations in which responses to treatment vary considerably for any given patient. Despite recent advances with DMARDs and targeted therapies such as tumor necrosis factor (TNF) inhibitors, some patients do not show adequate response and continue to show disease progression. That means there must be flexibility in producing the optimal clinical response.
The best response will employ the use of a full spectrum of clinical agents with different therapeutic targets. As a patient with RA, you must educate yourself to what is available.
Evidence shows that patients with refractory RA may benefit from the use of sequential medicines starting with DMARDS, going on to anti-TNF drugs, and then using second generation biologic remedies if these treatments fail to halt disease progression.
Also, in clinical research, there are a number of excellent options that remain open to you. If your rheumatologist is not doing clinical research, have them refer you to a rheumatologist who is.
Among the second generation drugs are anti-CD20 B-cell depleting agents such as rituximab (Rituxan) and inhibitors of T-cell activation such as Orencia (abatacept).
Results from randomized clinical trials have demonstrated improved outcomes as a result of treatment with these agents, in combination with methotrexate, even in patients who previously have not responded to DMARDs and TNF inhibitors.
In the near future, other agents such as anti-IL 6 (Actemra) and protein kinase inhibitors will add to the treatment regimen. Third and fourth generation biologic remedies show a great deal of promise in the research arena.
Both Amy Clark & Nathan Wei are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Amy Clark has sinced written about articles on various topics from Arthritis Signs, Arthritis Signs and Face Cream. To grab your Free Arthritis Relief Guide, and to read more articles related to Medications For Rheumatoid Art. Amy Clark's top article generates over 5400 views. Bookmark Amy Clark to your Favourites.
Nathan Wei has sinced written about articles on various topics from Arthritis Pain, Health and Arthritis Signs. Nathan Wei, MD FACP FACR is a rheumatologist and Director of the Arthritis and Osteoporosis Center of Maryland. He is a Clinical Assistant Professor of Medicine at the University of Maryland School of Medicine. For more info:. Nathan Wei's top article generates over 550000 views. Bookmark Nathan Wei to your Favourites.
Design Your Own Business Card Online So get started with your own business card as soon as you can and remember to make it put your best face forward